AnticoagEvaluator
Published by:
American College of Cardiology
Description
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Hide
Show More...
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Screenshots
AnticoagEvaluator FAQ
-
Is AnticoagEvaluator free?
Yes, AnticoagEvaluator is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is AnticoagEvaluator legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does AnticoagEvaluator cost?
AnticoagEvaluator is free.
-
What is AnticoagEvaluator revenue?
To get estimated revenue of AnticoagEvaluator app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Czechia yet.
Ratings History
AnticoagEvaluator Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
363
|
AnticoagEvaluator Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
WarfarinGuide
|
View
|
View
|
0
|
|
3 years ago | |
AHA Guidelines On-The-Go
|
View
|
View
|
0
|
|
5 months ago | |
Mayo Clinic Cardiovascular CME
View and earn CV CME on the go
|
View
|
View
|
0
|
|
1 year ago | |
Anticoagulation Manager
|
View
|
View
|
0
|
|
2 years ago | |
ACP Clinical Guidelines
|
View
|
View
|
0
|
|
2 weeks ago | |
Cardiology Clinical Questions.
Best Point-of-Care Q&A Guide
|
View
|
View
|
0
|
|
1 year ago | |
Cardiac Trials
Sharim's Cardiac Trials
|
View
|
View
|
0
|
|
2 years ago | |
MAQI2 Anticoagulation Toolkit
|
View
|
View
|
0
|
|
4 weeks ago | |
Preop Eval
from Joshua Steinberg MD
|
View
|
View
|
0
|
|
3 weeks ago | |
Aspirin Guide
|
View
|
View
|
0
|
|
2 years ago |
AnticoagEvaluator Installs
Last 30 days
AnticoagEvaluator Revenue
Last 30 daysAnticoagEvaluator Revenue and Downloads
Gain valuable insights into AnticoagEvaluator performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
American College of Cardiology
- Languages
- English
- Recent release
- 5.0.0.7 (1 month ago )
- Released on
- Mar 6, 2013 (11 years ago )
- Also available in
- United States, United Kingdom, Egypt, Australia, Italy, Brazil, Pakistan, Hungary, Colombia, Russia, Nigeria, Peru, New Zealand, Norway, Netherlands, Poland, Malaysia, Mexico, Lebanon, Kazakhstan, Kuwait, Philippines, India, Portugal, Romania, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Azerbaijan, Belgium, Belarus, Canada, Switzerland, Chile, China, Czechia, Germany, Denmark, South Korea, Algeria, Ecuador, Spain, Finland, France, Greece, Hong Kong SAR China, Indonesia, Ireland, Israel, United Arab Emirates, Japan
- Last Updated
- 1 day ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.